Separate names with a comma.
[IMG] https://www.linkedin.com/posts/mindmedco_bio2025-brainhealth-psychedelicmedicine-activity-7340033201014235136-HXgD Psychedelics are in...
Link for those who want to listen in: Today at 12PM EST #AlphaNooner – Christian Angermayer on Biotech, Bitcoin, and the Future of Mental Health...
Amazing movement... going to 1.00+ prior to uplist very soon. https://i.ibb.co/X6DB5r0/Screenshot-2025-06-06-112420.png betting on a possible...
Trump administration exploring potential benefits of psychedelic treatments Fox News correspondent Alexandria Hoff discusses the Trump...
NeuroGram+ Taking A Break from The Festival of Fools It might seem a shallow and all-too-brief flight from the daily tawdry display of malevolent...
Valuation set for 1.6B [IMG]
1.6B valuation at minimum... [IMG]
Watch $ATAI today with their merger news...
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer May 27, 2025 7:00 am EDT MindMed...
atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies June 2, 2025 atai Life Sciences...
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors...
FDA commissioner says research on psychedelic treatment ‘top priority' | On Balance [MEDIA]
Rising Leaders 2025: Rob Barrow On Leading MindMed’s Psychedelic Renaissance...
MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates...
Secretary of VA Collins mentioned yesterday in the 100 day cabinet meeting that evaluating psychedelic treatment for vets is a main focus. A lot...
Institutional investors own a significant stake of 50% in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)...
MindMed’s Bet on Psychedelic Psychiatry: Vanguards of Health Care...
MNMD - SCHEDULE 14A INFORMATION - Proxy Statement Notes...
MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)...
